ChIP-seq analysis of publicly available data (GSE207814) identified prominent H3K18la binding peaks at the AURKB promoter in H1299 cells (Fig. 3G), prompting further validation in CRC. This evidence concerns the gene AURKB and colorectal carcinoma.